We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
Ucore Advances Rare Earth Supply Chain with RapidSX Tech in U.S.
about 1 hour ago
Search Minerals' Coastal Edge in Rare Earth Race
about 2 hours ago
WLDS & Rokid Partner for Touch-Free Neural Control of AR Glasses
about 6 hours ago
Slips Secures $3.5M to Revolutionize Peer-to-Peer Betting
about 6 hours ago
HR News
IRS Alert: Avoid Costly Penalties with Proactive Payroll Record Reviews
about 13 hours ago
HR.com Honors 2026 Talent Acquisition Award Winners for Recruitment Excellence
1 day ago
HR Leaders Unite to Shape Future of People Analytics with AI Insights
2 days ago
JDXpert Launches JDX+: AI-Powered Platform Solves Job Data Chaos
9 days ago
HR Study: Talent Acquisition Crisis Costs Firms Billions, AI Offers Hope
9 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 8 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 8 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 4 months
HeartBeam Gains Industry Recognition for FDA-Cleared Cardiac Diagnostic Technology
about 1 hour ago
SEGG Media to Acquire Veloce in $61M Deal, Boosting Global Sports & Gaming Platform
about 2 hours ago
Crypto News
ZeroStack Hits $840K in 0G Token Staking Rewards, Boosting AI Asset Strategy
about 7 hours ago
NxGen Extends CAND Token Launch to Boost Liquidity Amid Market Volatility
about 7 hours ago
Forward Industries Reports Q1 as Solana Treasury, Posts $585M Loss Amid Staking Gains
about 7 hours ago
Chainlink Co-Founder: Crypto's Future Lies Beyond Price Charts
about 7 hours ago
SOLOWIN Holdings Secures $100M Deal to Boost Fintech Expansion
1 day ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 8 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 8 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 4 months
HeartBeam Gains Industry Recognition for FDA-Cleared Cardiac Diagnostic Technology
about 1 hour ago
LIXTE Advances Cancer Therapy LB-100 While Sponsoring Health Equity Summit
about 6 hours ago
Technology News
Ucore Advances Rare Earth Supply Chain with RapidSX Tech in U.S.
about 1 hour ago
SEGG Media to Acquire Veloce in $61M Deal, Boosting Global Sports & Gaming Platform
about 2 hours ago
Safe Pro Group Showcases AI Defense & Advanced Body Armor at SHOT Show 2026
about 3 hours ago
A2Z Cust2Mate's Smart Carts Transform Retail with In-Cart Checkout & AI
about 4 hours ago
WLDS & Rokid Partner for Touch-Free Neural Control of AR Glasses
about 6 hours ago
Events & Conferences
LIXTE Advances Cancer Therapy LB-100 While Sponsoring Health Equity Summit
about 6 hours ago
45Drives to Showcase Next-Gen Ceph Performance at Raleigh 2026 Event
1 day ago
Energy Fuels to Host 2025 Financial Results Call on Feb. 27, 2026
1 day ago
HR.com Honors 2026 Talent Acquisition Award Winners for Recruitment Excellence
1 day ago
Mayor Weiss Charts Pflugerville's Path: Growth with a Small-Town Heart
1 day ago